Cinnamaldehyde protects SH-SY5Y cells against advanced glycation end-products induced ectopic cell cycle re-entry
Open Access
- 17 June 2024
- journal article
- research article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 156 (1) , 1-8
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective reviewMolecular and Cellular Biochemistry, 2022
- Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stressFree Radical Biology and Medicine, 2022
- Model scenarios for cell cycle re-entry in Alzheimer's diseaseiScience, 2022
- History in Perspective: The prime pathological players and role of phytochemicals in Alzheimer’s diseaseIBRO Neuroscience Reports, 2022
- Plasma glycation adducts and various RAGE isoforms are intricately associated with oxidative stress and inflammatory markers in type 2 diabetes patients with vascular complicationsDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2022
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunitiesJournal of Biochemical and Molecular Toxicology, 2021
- Didymin, a dietary citrus flavonoid exhibits anti-diabetic complications and promotes glucose uptake through the activation of PI3K/Akt signaling pathway in insulin-resistant HepG2 cellsChemico-Biological Interactions, 2019
- Cinnamaldehyde potentially attenuates gestational hyperglycemia in rats through modulation of PPARγ, proinflammatory cytokines and oxidative stressBiomedicine & Pharmacotherapy, 2017
- mTOR Signaling in Growth, Metabolism, and DiseaseCell, 2017